Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

The retinoblastoma protein as a transcriptional repressor.

Helin K, Ed H.

Trends Cell Biol. 1993 Feb;3(2):43-6.

PMID:
14731718
2.

Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.

Higashi H, Suzuki-Takahashi I, Saitoh S, Segawa K, Taya Y, Okuyama A, Nishimura S, Kitagawa M.

Eur J Biochem. 1996 Apr 15;237(2):460-7.

3.

Chemical synthesis of phosphopeptides using the arylthio group for protection of phosphate: application to identification of cdc2 kinase phosphorylation sites.

Ueno Y, Makino S, Kitagawa M, Nishimura S, Taya Y, Hata T.

Int J Pept Protein Res. 1995 Aug;46(2):106-12.

PMID:
8567164
4.

Targets of cyclin-dependent protein kinases.

Nigg EA.

Curr Opin Cell Biol. 1993 Apr;5(2):187-93. Review.

PMID:
8507490
5.

The cdk2 kinase is required for the G1-to-S transition in mammalian cells.

Tsai LH, Lees E, Faha B, Harlow E, Riabowol K.

Oncogene. 1993 Jun;8(6):1593-602.

PMID:
8502482
6.

Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G.

Genes Dev. 1993 May;7(5):812-21.

7.

Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.

Pagano M, Pepperkok R, Lukas J, Baldin V, Ansorge W, Bartek J, Draetta G.

J Cell Biol. 1993 Apr;121(1):101-11.

8.
9.

Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.

Kitagawa M, Okabe T, Ogino H, Matsumoto H, Suzuki-Takahashi I, Kokubo T, Higashi H, Saitoh S, Taya Y, Yasuda H, et al.

Oncogene. 1993 Sep;8(9):2425-32.

PMID:
8395680
10.

The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.

Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ.

Genes Dev. 1993 Apr;7(4):555-69.

11.

Cyclin-dependent regulation of G1 in mammalian fibroblasts.

Ohtsubo M, Roberts JM.

Science. 1993 Mar 26;259(5103):1908-12.

PMID:
8384376
12.

Signals and genes in the control of cell-cycle progression.

Müller R, Mumberg D, Lucibello FC.

Biochim Biophys Acta. 1993 Aug 23;1155(2):151-79. Review. No abstract available.

PMID:
8357825
13.

Cyclins and cyclin-dependent kinases: take your partners.

Pines J.

Trends Biochem Sci. 1993 Jun;18(6):195-7. Review. No abstract available.

PMID:
8346551
14.

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.

Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM.

Cell. 1993 May 7;73(3):487-97.

PMID:
8343202
15.

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ.

Genes Dev. 1993 Aug;7(8):1559-71.

16.

Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E.

Genes Dev. 1993 Jul;7(7A):1111-25.

17.

Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation.

Mittnacht S, Lees JA, Desai D, Harlow E, Morgan DO, Weinberg RA.

EMBO J. 1994 Jan 1;13(1):118-27.

18.

CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G.

Oncogene. 1994 Jan;9(1):71-9.

PMID:
8302605
19.

Distinct roles for cyclin-dependent kinases in cell cycle control.

van den Heuvel S, Harlow E.

Science. 1993 Dec 24;262(5142):2050-4.

PMID:
8266103
20.

Inactivation of oncoprotein binding by a single Cys706-to-Tyr substitution in the retinoblastoma protein.

Saijo M, Kato MV, Sasaki MS, Ishizaki K, Taya Y.

FEBS Lett. 1994 Mar 7;340(3):181-4.

Supplemental Content

Support Center